Global Custom Recombinant Protein Production Services Market, by Expression System  (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$  2,600.21 million in 2017, and is projected to exhibit a CAGR of 11.2% over the forecast period (2018 – 2026), as highlighted in a new report published by .

Increasing research and development of product and services by market players to augment the market growth

Key players in the market are focused on research and development in order to cater the demand of researchers for proteins production having wide applications in medicine, research, and biotechnology.  For instance, in 2015, Abgent offer ELITE custom antibody services, including custom antibody development, custom peptide synthesis, and custom protein expression services.

Moreover, the market players are focused launching facilities to increase production capacity and expand their offerings and services, which is expected to boost the market growth. For instance, in February 2018, Lakepharma, Inc. established a new facility in Massachusetts to offer fully integrated Contract Development and Manufacturing Organization (CDMO) services, thereby providing end-to-end services to partners and clients. Similarly, in February 2018, Lakepharma, Inc. launched LakePharma MicroBiomanufacturing Center in Hopkinton, Massachusetts to enhance its ability to offer product development and manufacturing.

Furthermore, increasing expenditure on research and development is expected to boost the market growth. For instance, according to the National Bureau of Statistics, February 2018,  China’s expenditure on research and development increased by 11.6% in 2017 from 10.6% in 2016 reaching to US$ 280 Bn in 2017.

Browse 37 Market Data Tables and 29 Figures spread through 190 Pages and in-depth TOC on ‘Custom Recombinant Protein Production Services Market’- Global Forecast to 2026, by Expression System  (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the custom recombinant protein production services market, click the link below:

https://www.coherentmarketinsights.com/market-insight/custom-recombinant-protein-production-services-market-2737

Key players in the market are focused on adopting strategies such as collaborations and acquisitions to enhance their service offerings. For instance, in 2017, Eurofins acquired Villapharma Research SL based in Spain to expand its portfolio of services into comprehensive offering and further strengthen its service proposition for the pharmaceutical and biotech industries.

Key Takeaways of the Custom Recombinant Protein Production Services Market:

  • The global custom recombinant protein production services market is expected to exhibit a CAGR of 11.2% over the forecast period. This is owing advancements in bioreactor systems that have reduced production time for recombinant proteins. For instance, according to National Center for Biotechnology Information (NCBI), in 2014, around 65.6% of clinical scale manufacturers and 42% of commercial manufacturers adopted single use bioreactors for improvement in their bioprocessing.
  • Among expression systems, the mammalian segment held a dominant position in the custom recombinant protein production services market in 2018. This is owing to the ability of mammalian expression to offer optimized transient system for rapid yield of protein production.
  • Among end users, biotechnology and pharmaceutical companies segment held a dominant position in the custom recombinant protein production services market in 2018, owing to increasing number of research and development activities. According to Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member companies invested an estimated US$ 58.8 billion in research and development in 2015, which was the majority of all biopharmaceutical R&D spending in the U.S.
  • Key players operating in the global custom recombinant protein production services market include, GenScript Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc., BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech, Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc., Proteos, Inc., Aldevron, and Sino Biological Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: